Follow
Ella Goldschmidt
Title
Cited by
Cited by
Year
Frequent aneuploidy in primary human T cells after CRISPR–Cas9 cleavage
AD Nahmad, E Reuveni, E Goldschmidt, T Tenne, M Liberman, ...
Nature biotechnology 40 (12), 1807-1813, 2022
1272022
Shared transcriptional profiles of atypical B cells suggest common drivers of expansion and function in malaria, HIV, and autoimmunity
P Holla, B Dizon, AA Ambegaonkar, N Rogel, E Goldschmidt, ...
Science Advances 7 (22), eabg8384, 2021
832021
Pan-cancer mapping of single T cell profiles reveals a TCF1: CXCR6-CXCL16 regulatory axis essential for effective anti-tumor immunity
L Jerby-Arnon, K Tooley, G Escobar, G Dandekar, A Madi, E Goldschmidt, ...
bioRxiv, 2021.10. 31.466532, 2021
72021
Shared transcriptional profiles of atypical B cells suggest common drivers of expansion and function in malaria, HIV, and autoimmunity. Sci. Adv. 7, eabg8384
P Holla, B Dizon, AA Ambegaonkar, N Rogel, E Goldschmidt, ...
52021
Frequent Aneuploidy in Primary Human T Cells Following CRISPR-Cas9 cleavage
AD Nahmad, E Reuveni, E Goldschmidt, T Tenne, M Liberman, ...
bioRxiv, 2021.08. 20.457092, 2021
12021
Frequent Aneuploidy in Primary Human T Cells Following CRISPR-Cas9 cleavage
AD Nahmad, E Reuveni, E Goldschmidt, T Tenne, M Liberman, ...
Nature 559, 405-409, 2018
12018
Pan-cancer mapping of single CD8+ T cell profiles reveals a TCF1: CXCR6 axis regulating CD28 co-stimulation and anti-tumor immunity
K Tooley, L Jerby, G Escobar, SH Krovi, D Mangani, G Dandekar, ...
Cell Reports Medicine, 2024
2024
FREQUENT CRISPR-CAS9 INDUCED ANEUPLOIDY IN PRIMARY HUMAN T CELLS
A Nahmad, E Reuveni, E Goldschmidt, T Tenne, M Liberman, ...
HUMAN GENE THERAPY 33 (7-8), A4-A4, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–8